• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

rs2267531 是 X 染色体上聚糖蛋白 3 基因中的启动子 SNP,与埃及人的肝细胞癌相关。

rs2267531, a promoter SNP within glypican-3 gene in the X chromosome, is associated with hepatocellular carcinoma in Egyptians.

机构信息

Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt.

出版信息

Sci Rep. 2019 May 3;9(1):6868. doi: 10.1038/s41598-019-43376-3.

DOI:10.1038/s41598-019-43376-3
PMID:31053802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6499880/
Abstract

Hepatocellular carcinoma (HCC) is a major health concern in Egypt owing to the high prevalence of hepatitis C virus (HCV) infection. HCC incidence is characterized by obvious male predominance, yet the molecular mechanisms behind this gender bias are still unidentified. Functional variations in X-linked genes have more impact on males than females. Glypican-3 (GPC3) gene, located in the Xq26 region, has lately emerged as being potentially implicated in hepatocellular carcinogenesis. The current study was designed to examine the association of -784 G/C single nucleotide polymorphism (SNP) in GPC3 promoter region (rs2267531) with HCC susceptibility in male and female Egyptian HCV patients. Our results revealed a significant association between GPC3 and HCC risk in both males and females, evidenced by higher C allele and CC/C genotype frequencies in HCC patients when compared to controls. However, no such association was found when comparing HCV patients to controls. Moreover, GPC3 gene and protein expression levels were significantly higher in CC/C than in GG/G genotype carriers in males and females. The CC/C genotype exhibited a significant shorter overall survival than GG/G genotype in HCC patients. In conclusion, GPC3 rs2267531 on the X chromosome is significantly associated with HCC, but not with HCV infection, in the Egyptian population.

摘要

肝细胞癌 (HCC) 在埃及是一个主要的健康关注点,这是由于丙型肝炎病毒 (HCV) 感染的高流行率所致。HCC 的发病率具有明显的男性优势,但导致这种性别偏见的分子机制仍未确定。X 连锁基因的功能变异对男性的影响大于女性。位于 Xq26 区域的 GPC3 基因(glypican-3)最近被认为可能与肝细胞癌的发生有关。本研究旨在探讨 GPC3 启动子区域(rs2267531)-784 G/C 单核苷酸多态性 (SNP) 与埃及男性和女性 HCV 患者 HCC 易感性的关系。我们的研究结果表明,GPC3 与 HCC 风险在男性和女性中均存在显著相关性,与对照组相比,HCC 患者的 C 等位基因和 CC/C 基因型频率更高。然而,在将 HCV 患者与对照组进行比较时,并未发现这种相关性。此外,在男性和女性中,CC/C 基因型携带者的 GPC3 基因和蛋白表达水平均显著高于 GG/G 基因型携带者。与 GG/G 基因型携带者相比,CC/C 基因型携带者的 HCC 患者总生存期明显缩短。总之,X 染色体上的 GPC3 rs2267531 与埃及人群的 HCC 显著相关,但与 HCV 感染无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ac/6499880/b55edbe30963/41598_2019_43376_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ac/6499880/2673edfc1180/41598_2019_43376_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ac/6499880/98d1c7496970/41598_2019_43376_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ac/6499880/b55edbe30963/41598_2019_43376_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ac/6499880/2673edfc1180/41598_2019_43376_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ac/6499880/98d1c7496970/41598_2019_43376_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ac/6499880/b55edbe30963/41598_2019_43376_Fig3_HTML.jpg

相似文献

1
rs2267531, a promoter SNP within glypican-3 gene in the X chromosome, is associated with hepatocellular carcinoma in Egyptians.rs2267531 是 X 染色体上聚糖蛋白 3 基因中的启动子 SNP,与埃及人的肝细胞癌相关。
Sci Rep. 2019 May 3;9(1):6868. doi: 10.1038/s41598-019-43376-3.
2
Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.评估循环转化生长因子-β1、磷脂酰聚糖-3 和高尔基糖蛋白-73 mRNA 表达作为埃及患者肝细胞癌的预测标志物。
Mol Biol Rep. 2013 Dec;40(12):7069-75. doi: 10.1007/s11033-013-2829-3. Epub 2013 Nov 2.
3
Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.磷脂酰肌醇蛋白聚糖-3在肝硬化患者肝细胞癌早期检测中的意义
J Gastrointest Cancer. 2019 Sep;50(3):434-441. doi: 10.1007/s12029-018-0095-2.
4
Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma.评价 Glypican 3 启动子在肝细胞癌转录靶向治疗中的作用。
Gene Ther. 2018 Apr;25(2):115-128. doi: 10.1038/s41434-018-0002-2. Epub 2018 Mar 21.
5
Soluble cluster of differentiation 26/soluble dipeptidyl peptidase-4 and glypican-3 are promising serum biomarkers for the early detection of Hepatitis C virus related hepatocellular carcinoma in Egyptians.可溶性分化簇 26/可溶性二肽基肽酶-4 和糖蛋白 3 是埃及人丙型肝炎病毒相关肝细胞癌早期检测有前途的血清生物标志物。
Arab J Gastroenterol. 2020 Dec;21(4):224-232. doi: 10.1016/j.ajg.2020.04.016. Epub 2020 Sep 3.
6
Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.长链非编码RNA磷脂酰肌醇蛋白聚糖3(GPC3)反义转录本1通过表观遗传激活GPC3促进肝细胞癌进展。
FEBS J. 2016 Oct;283(20):3739-3754. doi: 10.1111/febs.13839. Epub 2016 Sep 21.
7
The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.长链非编码 RNA 基因的表达与肝癌和 HBV 埃及患者中 HULC rs7763881 和 MALAT1 rs619586 多态性的表达相关。
J Cell Biochem. 2019 Sep;120(9):14645-14656. doi: 10.1002/jcb.28726. Epub 2019 Apr 22.
8
Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.肝硬化(LC)和肝细胞癌(HCC)患者血浆中循环miR-1291的临床影响:对磷脂酰肌醇蛋白聚糖-3表达的影响
J Gastrointest Cancer. 2020 Mar;51(1):234-241. doi: 10.1007/s12029-019-00234-9.
9
Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.核酸减少的ZHX2参与人肝细胞癌中磷脂酰肌醇蛋白聚糖3的致癌激活。
Int J Biochem Cell Biol. 2014 Oct;55:129-35. doi: 10.1016/j.biocel.2014.08.021. Epub 2014 Sep 6.
10
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.磷脂酰肌醇蛋白聚糖-3在人类肝细胞癌中特异性过表达,是一种新型肿瘤标志物。
Biochem Biophys Res Commun. 2003 Jun 20;306(1):16-25. doi: 10.1016/s0006-291x(03)00908-2.

引用本文的文献

1
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges.肝细胞癌的免疫治疗与肝移植:当前及未来挑战
World J Transplant. 2025 Jun 18;15(2):98509. doi: 10.5500/wjt.v15.i2.98509.
2
Sex and gender disparities in hepatocellular carcinoma: insights into risk, diagnosis, and therapeutic outcomes.肝细胞癌中的性别差异:对风险、诊断和治疗结果的见解。
Clin Transl Oncol. 2025 Jun 17. doi: 10.1007/s12094-025-03965-3.
3
Circular SERPINA3 and its target microRNA-944 as potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma in Egyptian population.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.雌激素受体在慢性丙型肝炎和肝细胞癌发病机制中的表达。
World J Gastroenterol. 2017 Oct 7;23(37):6802-6816. doi: 10.3748/wjg.v23.i37.6802.
3
Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States.
环状丝氨酸蛋白酶抑制剂3及其靶标微小RNA-944作为埃及人群丙型肝炎病毒诱导的肝细胞癌的潜在生物标志物。
Noncoding RNA Res. 2023 May 23;8(3):401-412. doi: 10.1016/j.ncrna.2023.05.005. eCollection 2023 Sep.
4
Association between GPC2 polymorphisms and neuroblastoma risk in Chinese children.GPC2 多态性与中国儿童神经母细胞瘤风险的关联。
J Clin Lab Anal. 2023 Mar;37(5):e24866. doi: 10.1002/jcla.24866. Epub 2023 Mar 15.
5
Frequently expressed glypican-3 as a promising novel therapeutic target for osteosarcomas.高表达的磷脂酰聚糖-3 作为骨肉瘤有前途的新型治疗靶点。
Cancer Sci. 2022 Oct;113(10):3618-3632. doi: 10.1111/cas.15521. Epub 2022 Aug 21.
6
rs62139665 Polymorphism in the Promoter Region of EpCAM Is Associated With Hepatitis C Virus-Related Hepatocellular Carcinoma Risk in Egyptians.EpCAM启动子区域的rs62139665多态性与埃及人丙型肝炎病毒相关肝细胞癌风险相关。
Front Oncol. 2022 Jan 5;11:754104. doi: 10.3389/fonc.2021.754104. eCollection 2021.
7
Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine.癌症中的非编码变异:个性化医学的机制见解与临床潜力
Noncoding RNA. 2021 Aug 2;7(3):47. doi: 10.3390/ncrna7030047.
美国肝细胞癌发病率的年龄特异性性别差异。
Oncotarget. 2017 Jul 12;8(40):68131-68137. doi: 10.18632/oncotarget.19245. eCollection 2017 Sep 15.
4
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.磷脂酰聚糖蛋白 3:一种有前途的肝细胞癌诊断和治疗的生物标志物。
Med Res Rev. 2018 Mar;38(2):741-767. doi: 10.1002/med.21455. Epub 2017 Jun 16.
5
Hepatitis C infection in Egypt: prevalence, impact and management strategies.埃及的丙型肝炎感染:患病率、影响及管理策略。
Hepat Med. 2017 May 15;9:17-25. doi: 10.2147/HMER.S113681. eCollection 2017.
6
Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature.南亚人群中的非酒精性脂肪性肝病:文献综述
J Clin Transl Hepatol. 2017 Mar 28;5(1):76-81. doi: 10.14218/JCTH.2016.00045. Epub 2017 Feb 7.
7
Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.细胞色素P450 1A2将17β-雌二醇代谢以抑制肝细胞癌。
PLoS One. 2016 Apr 19;11(4):e0153863. doi: 10.1371/journal.pone.0153863. eCollection 2016.
8
Testing for Hardy-Weinberg equilibrium at biallelic genetic markers on the X chromosome.检测X染色体上双等位基因遗传标记的哈迪-温伯格平衡。
Heredity (Edinb). 2016 Jun;116(6):558-68. doi: 10.1038/hdy.2016.20. Epub 2016 Apr 13.
9
Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.评估磷脂酰肌醇蛋白聚糖3作为肝细胞癌血清诊断标志物的临床应用价值。
Technol Cancer Res Treat. 2016 Dec;15(6):780-786. doi: 10.1177/1533034615605248. Epub 2015 Sep 14.
10
Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.Glypican-3在乙型肝炎病毒相关性肝细胞癌肝移植患者中的预后价值。
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):157-63. doi: 10.1016/s1499-3872(15)60349-6.